35 products added to the April 2021 Discount Not Deducted (DND) list

35 products added to the April 2021 Discount Not Deducted (DND) list

April 1, 2021

Following applications made by PSNC to the Department of Health and Social Care (DHSC) and the NHS Business Services Authority (NHSBSA), a further 35 new products will enter the list of ‘Drugs for which Discount is Not Deducted’ (DND) in Part II of the Drug Tariff from 1 April 2021. This takes the total number of products granted DND status over the past 12 months to over 300 following checks made by PSNC.

Domperidone 1mg/ml oral suspension sugar free, Ongentys 50mg capsules and Plenadren 5mg modified-release tablets are among the new products added to the DND list to which the discount deduction scale will no longer apply from April 2021.

Click here to view the 35 products added to DND list on 1st April 2021:

  • Almuriva 4.6mg/24hours transdermal patches
  • Aripiprazole 1mg/ml oral solution sugar free
  • Arpoya 10mg tablets
  • Arpoya 5mg tablets
  • Atropine 1mg/1ml solution for injection ampoules
  • Betaloc I.V. 5mg/5ml solution for injection ampoules
  • Captopril 5mg/5ml oral solution sugar free
  • Catephen 10% ointment
  • Ceftriaxone 2g powder for solution for injection vials
  • Ceptava 360mg gastro-resistant tablets
  • Co-danthrusate 50mg/60mg/5ml oral suspension sugar free
  • Domperidone 1mg/ml oral suspension sugar free
  • Ferinject 1000mg/20ml solution for injection vials
  • Grazax 75,000 SQ-T oral lyophilisates
  • Leflunomide 15mg tablets
  • Malarivon 80mg/5ml syrup
  • Mycophenolic acid 360mg gastro-resistant tablets
  • Noyada 5mg/5ml oral solution
  • Ongentys 50mg capsules
  • Opsumit 10mg tablets
  • Pancrex V oral powder
  • Plenadren 5mg modified-release tablets
  • Polyfusor W water for infusion 1litre bottles
  • Polyfusor W water for infusion 500ml bottles
  • Prezista 100mg/ml oral suspension
  • Prometax 4.6mg/24hours transdermal patches
  • Rezolsta 800mg/150mg tablets
  • Rocephin 2g powder for solution for injection vials
  • Ropiqual XL 4mg tablets
  • Sodium valproate 400mg/4ml solution for injection ampoules
  • Strontium ranelate 2g granules sachets sugar free
  • Symtuza 800mg/150mg/200mg/10mg tablets
  • Teglutik 5mg/1ml oral suspension
  • Topogyne 400microgram tablets
  • Zytiga 500mg tablets

For a list of all the monthly changes to the DND status of products please see the following page Notice of changes to discount not deducted (DND) status of products.


Background

The DND list is updated monthly by the DHSC and includes grouped and individual items. Individual items are separately listed in Part II of the Drug Tariff. Any items covered by the ‘Group Items’ heading are not listed again individually in Part II. Contractors can also check the Actual Medicinal Product (AMP) listing on Dictionary of Medicines and Devices (dm+d) to identify whether a product meets the DND criteria (see below).

Group items

Any products that are covered by one or more of the Group items categories below are reimbursed without any discount deduction applied.

  • Cold Chain Storage (ALL)
  • Schedule 1, 2 or 3 Controlled Drugs: Products containing drugs listed in Schedules 1, 2 and 3 of the Misuse of Drugs Regulation 2001
  • Cytotoxic or Cytostatic item (ALL):
  • Immunoglobulins (ALL)
  • Insulins for injection (ALL)
  • Vaccines and antisera (ALL)
  • Unlicensed medicines: ‘Specials’ not listed in Part VIIIB where the product has been sourced from a supplier holding a MHRA specials or importers licence (prescriptions must be endorsed with invoice price less discount/rebate)
  • Hazardous chemicals

Individual items  

Products that do not are covered by one or more of the Group item categories above must fulfil all three of the following criteria to qualify for entry to the DND list.

  • the manufacturer(s), AAH and Alliance do not offer pharmacy contractors a discount
  • fewer than 500,000 items per year are dispensed of the product
  • average net ingredient cost (NIC) per item is more than £50

PSNC will continue its work to assess whether other drugs and appliances fulfil the current DND entry requirements under either the ‘Group’ and ‘Individual item’ criteria and make applications to NHSBSA and DHSC, accordingly.

If a product is currently subject to the discount deduction scale and you believe that it should be added to DND list based on the criteria specified above, please contact the PSNC Dispensing and Supply Team by emailing info@psnc.org.uk who will investigate whether the product meets the relevant DND criteria and make an application to the DHSC and NHSBSA, as appropriate.

For further information on how discount deduction works, click here



Posted in: , ,


More Latest News >